SpringWorks will add two FDA-approved products to Merck's portfolio, namely Ogsiveo (nirogacestat), a drug for desmoid tumours – which accounted for all its 2024 revenues of $172 million – and ...

told cattle feeders this week it will no longer buy animals fed a supplement that's designed ... Zilmax manufacturer Merck Animal Health said in an emailed statement Friday that its product ...

Merck & Co., Inc. operates as a healthcare company ... vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? Did you know you’re supposed to eat at least five servings of fruits and ...

June 12, 2025 Exclusive: Kennedy's new vaccine adviser was expert witness against Merck vaccine One of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned ...

Overview: Magnesium supplements are taken to increase magnesium levels. Common side effects include nausea, diarrhea, or stomach cramps. Serious side effects are rare, unless you take too much.

Hard on the heels of the disclosure that Merck KGaA is talking to SpringWorks about a possible takeover, a new FDA approval could have sweetened the deal. Stamford, Connecticut-based SpringWorks ...

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno ...

Merck recently announced a third-quarter dividend affirmation of $0.81 per share, underscoring its commitment to returning value to shareholders. Over the past week, the company's stock remained ...